Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012–2020 is a research paper published in The Journal of Clinical Pharmacology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural FDA HHS
Grant: FD999999
FWCI
2.16
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords